Copyright
©The Author(s) 2016.
World J Hepatol. Jan 18, 2016; 8(2): 92-106
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Figure 1 Hepatitis C virus replicative cycle and main targets for direct acting antiviral agents.
Modified from Manns and Cornberg. Lancet Infectious Diseases 2013. PIs: Protease inhibitors; NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors.
- Citation: Bertino G, Ardiri A, Proiti M, Rigano G, Frazzetto E, Demma S, Ruggeri MI, Scuderi L, Malaguarnera G, Bertino N, Rapisarda V, Di Carlo I, Toro A, Salomone F, Malaguarnera M, Bertino E, Malaguarnera M. Chronic hepatitis C: This and the new era of treatment. World J Hepatol 2016; 8(2): 92-106
- URL: https://www.wjgnet.com/1948-5182/full/v8/i2/92.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i2.92